Chapter/Section Purchase

1 Study Coverage
1.1 Leukocyte Surface Antigen CD47 Product Introduction
1.2 Market by Type
1.2.1 Global Leukocyte Surface Antigen CD47 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 B-6H12
1.2.3 ALX-148
1.2.4 CC-90002
1.2.5 PSTx-23
1.2.6 Others
1.3 Market by Application
1.3.1 Global Leukocyte Surface Antigen CD47 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Lymphoma
1.3.3 Ovarian Cancer
1.3.4 Ischemia Reperfusion Injury
1.3.5 Kindney Transplant Rejection
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Leukocyte Surface Antigen CD47 Sales Estimates and Forecasts 2017-2028
2.2 Global Leukocyte Surface Antigen CD47 Revenue Estimates and Forecasts 2017-2028
2.3 Global Leukocyte Surface Antigen CD47 Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Leukocyte Surface Antigen CD47 Sales by Region
2.4.1 Global Leukocyte Surface Antigen CD47 Sales by Region (2017-2022)
2.4.2 Global Sales Leukocyte Surface Antigen CD47 by Region (2023-2028)
2.5 Global Leukocyte Surface Antigen CD47 Revenue by Region
2.5.1 Global Leukocyte Surface Antigen CD47 Revenue by Region (2017-2022)
2.5.2 Global Leukocyte Surface Antigen CD47 Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Leukocyte Surface Antigen CD47 Sales by Manufacturers
3.1.1 Global Top Leukocyte Surface Antigen CD47 Manufacturers by Sales (2017-2022)
3.1.2 Global Leukocyte Surface Antigen CD47 Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Leukocyte Surface Antigen CD47 in 2021
3.2 Global Leukocyte Surface Antigen CD47 Revenue by Manufacturers
3.2.1 Global Leukocyte Surface Antigen CD47 Revenue by Manufacturers (2017-2022)
3.2.2 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Leukocyte Surface Antigen CD47 Revenue in 2021
3.3 Global Leukocyte Surface Antigen CD47 Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Leukocyte Surface Antigen CD47 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Leukocyte Surface Antigen CD47 Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Leukocyte Surface Antigen CD47 Sales by Type
4.1.1 Global Leukocyte Surface Antigen CD47 Historical Sales by Type (2017-2022)
4.1.2 Global Leukocyte Surface Antigen CD47 Forecasted Sales by Type (2023-2028)
4.1.3 Global Leukocyte Surface Antigen CD47 Sales Market Share by Type (2017-2028)
4.2 Global Leukocyte Surface Antigen CD47 Revenue by Type
4.2.1 Global Leukocyte Surface Antigen CD47 Historical Revenue by Type (2017-2022)
4.2.2 Global Leukocyte Surface Antigen CD47 Forecasted Revenue by Type (2023-2028)
4.2.3 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2017-2028)
4.3 Global Leukocyte Surface Antigen CD47 Price by Type
4.3.1 Global Leukocyte Surface Antigen CD47 Price by Type (2017-2022)
4.3.2 Global Leukocyte Surface Antigen CD47 Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Leukocyte Surface Antigen CD47 Sales by Application
5.1.1 Global Leukocyte Surface Antigen CD47 Historical Sales by Application (2017-2022)
5.1.2 Global Leukocyte Surface Antigen CD47 Forecasted Sales by Application (2023-2028)
5.1.3 Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2017-2028)
5.2 Global Leukocyte Surface Antigen CD47 Revenue by Application
5.2.1 Global Leukocyte Surface Antigen CD47 Historical Revenue by Application (2017-2022)
5.2.2 Global Leukocyte Surface Antigen CD47 Forecasted Revenue by Application (2023-2028)
5.2.3 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2017-2028)
5.3 Global Leukocyte Surface Antigen CD47 Price by Application
5.3.1 Global Leukocyte Surface Antigen CD47 Price by Application (2017-2022)
5.3.2 Global Leukocyte Surface Antigen CD47 Price Forecast by Application (2023-2028)
6 North America
6.1 North America Leukocyte Surface Antigen CD47 Market Size by Type
6.1.1 North America Leukocyte Surface Antigen CD47 Sales by Type (2017-2028)
6.1.2 North America Leukocyte Surface Antigen CD47 Revenue by Type (2017-2028)
6.2 North America Leukocyte Surface Antigen CD47 Market Size by Application
6.2.1 North America Leukocyte Surface Antigen CD47 Sales by Application (2017-2028)
6.2.2 North America Leukocyte Surface Antigen CD47 Revenue by Application (2017-2028)
6.3 North America Leukocyte Surface Antigen CD47 Market Size by Country
6.3.1 North America Leukocyte Surface Antigen CD47 Sales by Country (2017-2028)
6.3.2 North America Leukocyte Surface Antigen CD47 Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Leukocyte Surface Antigen CD47 Market Size by Type
7.1.1 Europe Leukocyte Surface Antigen CD47 Sales by Type (2017-2028)
7.1.2 Europe Leukocyte Surface Antigen CD47 Revenue by Type (2017-2028)
7.2 Europe Leukocyte Surface Antigen CD47 Market Size by Application
7.2.1 Europe Leukocyte Surface Antigen CD47 Sales by Application (2017-2028)
7.2.2 Europe Leukocyte Surface Antigen CD47 Revenue by Application (2017-2028)
7.3 Europe Leukocyte Surface Antigen CD47 Market Size by Country
7.3.1 Europe Leukocyte Surface Antigen CD47 Sales by Country (2017-2028)
7.3.2 Europe Leukocyte Surface Antigen CD47 Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Leukocyte Surface Antigen CD47 Market Size by Type
8.1.1 Asia Pacific Leukocyte Surface Antigen CD47 Sales by Type (2017-2028)
8.1.2 Asia Pacific Leukocyte Surface Antigen CD47 Revenue by Type (2017-2028)
8.2 Asia Pacific Leukocyte Surface Antigen CD47 Market Size by Application
8.2.1 Asia Pacific Leukocyte Surface Antigen CD47 Sales by Application (2017-2028)
8.2.2 Asia Pacific Leukocyte Surface Antigen CD47 Revenue by Application (2017-2028)
8.3 Asia Pacific Leukocyte Surface Antigen CD47 Market Size by Region
8.3.1 Asia Pacific Leukocyte Surface Antigen CD47 Sales by Region (2017-2028)
8.3.2 Asia Pacific Leukocyte Surface Antigen CD47 Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Leukocyte Surface Antigen CD47 Market Size by Type
9.1.1 Latin America Leukocyte Surface Antigen CD47 Sales by Type (2017-2028)
9.1.2 Latin America Leukocyte Surface Antigen CD47 Revenue by Type (2017-2028)
9.2 Latin America Leukocyte Surface Antigen CD47 Market Size by Application
9.2.1 Latin America Leukocyte Surface Antigen CD47 Sales by Application (2017-2028)
9.2.2 Latin America Leukocyte Surface Antigen CD47 Revenue by Application (2017-2028)
9.3 Latin America Leukocyte Surface Antigen CD47 Market Size by Country
9.3.1 Latin America Leukocyte Surface Antigen CD47 Sales by Country (2017-2028)
9.3.2 Latin America Leukocyte Surface Antigen CD47 Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Leukocyte Surface Antigen CD47 Market Size by Type
10.1.1 Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Type (2017-2028)
10.1.2 Middle East and Africa Leukocyte Surface Antigen CD47 Revenue by Type (2017-2028)
10.2 Middle East and Africa Leukocyte Surface Antigen CD47 Market Size by Application
10.2.1 Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Application (2017-2028)
10.2.2 Middle East and Africa Leukocyte Surface Antigen CD47 Revenue by Application (2017-2028)
10.3 Middle East and Africa Leukocyte Surface Antigen CD47 Market Size by Country
10.3.1 Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Country (2017-2028)
10.3.2 Middle East and Africa Leukocyte Surface Antigen CD47 Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Aurigene Discovery Technologies Ltd
11.1.1 Aurigene Discovery Technologies Ltd Corporation Information
11.1.2 Aurigene Discovery Technologies Ltd Overview
11.1.3 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Aurigene Discovery Technologies Ltd Recent Developments
11.2 Celgene Corp
11.2.1 Celgene Corp Corporation Information
11.2.2 Celgene Corp Overview
11.2.3 Celgene Corp Leukocyte Surface Antigen CD47 Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Celgene Corp Leukocyte Surface Antigen CD47 Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Celgene Corp Recent Developments
11.3 Forty Seven Inc
11.3.1 Forty Seven Inc Corporation Information
11.3.2 Forty Seven Inc Overview
11.3.3 Forty Seven Inc Leukocyte Surface Antigen CD47 Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Forty Seven Inc Leukocyte Surface Antigen CD47 Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Forty Seven Inc Recent Developments
11.4 Surface Oncology Inc
11.4.1 Surface Oncology Inc Corporation Information
11.4.2 Surface Oncology Inc Overview
11.4.3 Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Surface Oncology Inc Leukocyte Surface Antigen CD47 Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Surface Oncology Inc Recent Developments
11.5 Trillium Therapeutics Inc
11.5.1 Trillium Therapeutics Inc Corporation Information
11.5.2 Trillium Therapeutics Inc Overview
11.5.3 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Trillium Therapeutics Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Leukocyte Surface Antigen CD47 Industry Chain Analysis
12.2 Leukocyte Surface Antigen CD47 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Leukocyte Surface Antigen CD47 Production Mode & Process
12.4 Leukocyte Surface Antigen CD47 Sales and Marketing
12.4.1 Leukocyte Surface Antigen CD47 Sales Channels
12.4.2 Leukocyte Surface Antigen CD47 Distributors
12.5 Leukocyte Surface Antigen CD47 Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Leukocyte Surface Antigen CD47 Industry Trends
13.2 Leukocyte Surface Antigen CD47 Market Drivers
13.3 Leukocyte Surface Antigen CD47 Market Challenges
13.4 Leukocyte Surface Antigen CD47 Market Restraints
14 Key Findings in The Global Leukocyte Surface Antigen CD47 Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer